Shijiazhuang Yiling Pharmaceutical Co., Ltd.
002603
Rangering i aksjer
#4253
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and... Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
Aksjekurs
$2.24
Markedsverdi
$3.74B
Endring (1 dag)
0.59%
Endring (1 år)
-8.63%
Land
CN
Handel Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Kategori
Healthcare
Utbytteavkastning for Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (aksjesymbol: 002603) sin utbytteavkastning (TTM) per 2023-12-31 er: 2.17%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 1.71%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 1.71%
Utbytteavkastning for Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603) fra 2008 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
| År | Utbytteavkastning | Endre |
|---|---|---|
| 2026 (TTM) | 5.32% | 280.00% |
| 2024 | 1.40% | -35.48% |
| 2023 | 2.17% | 287.50% |
| 2022 | 0.56% | -84.62% |
| 2021 | 3.64% | 366.67% |
| 2020 | 0.78% | -3.70% |
| 2019 | 0.81% | -20.59% |
| 2018 | 1.02% | 72.88% |
| 2017 | 0.59% | 31.11% |
| 2016 | 0.45% | 55.17% |
| 2015 | 0.29% | -14.71% |
| 2014 | 0.34% | 9.68% |
| 2013 | 0.31% | 10.71% |
| 2012 | 0.28% | -26.32% |
| 2011 | 0.38% | 1,166.67% |
| 2010 | 0.03% | 200.00% |
| 2009 | 0.01% | -98.25% |
| 2008 | 0.57% | 0.00% |
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
| Selskap | Utbytteavkastning | Land |
|---|---|---|
| 1.57% |
US
|
|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 0.00% |
US
|
